Abstract
Objectives Identify high-risk clinical characteristics for a serious cause of vertigo in patients presenting to the emergency department.
Design Multicentre prospective cohort study over 3 years.
Setting Three university-affiliated tertiary care emergency departments.
Participants Patients presenting with vertigo, dizziness or imbalance. A total of 2078 of 2618 potentially eligible patients (79.4%) were enrolled (mean age 77.1 years; 59% women).
Main outcome measurements An adjudicated serious diagnosis defined as stroke, transient ischemic attack, vertebral artery dissection or brain tumour.
Results Serious events occurred in 111 (5.3%) patients. We used logistic regression to create a 7-item prediction model: male, age over 65, hypertension, diabetes, motor/sensory deficits, cerebellar signs/symptoms and benign paroxysmal positional vertigo diagnosis (C-statistic 0.96, 95% confidence interval [CI] 0.92–0.98). The risk of a serious diagnosis ranged from 0% for a score of <5, 2.1% for a score of 5-8, and 41% for a score >8. Sensitivity for a serious diagnosis was 100% (95% CI, 97.1-100%) and specificity 72.1% (95% CI, 70.1-74%) for a score <5.
Conclusions The Sudbury Vertigo Risk Score identifies the risk of a serious diagnosis as a cause of a patient’s vertigo and can assist physicians in guiding further investigation, consultation and treatment decisions, improving resource utilization and reducing missed diagnoses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Physician Services Incorporated, NOAMA
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health Sciecnes North Institutional Ethics Board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Available on request
